Antony C. Mattessich, President and CEO at OCULAR THERAPEUTIX, INC (OCUL), sold 19,642 shares at $4.86 ($95K) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Scheduled sale ($95k) by President and CEO.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2023-02-08 | $167K | — | Filing → |
| OCUL | BUY | 2021-08-24 | $49K | — | Filing → |
| OCUL | BUY | 2019-06-10 | $112K | — | Filing → |